ICD code T52.0X3D – Toxic effect of petroleum products, assault

Key takeaways

T52.0X3D is a billable ICD-10-CM code for a follow-up visit after another person exposed the patient to a petroleum product.

The 6th character 3 means assault, and the record has to say so. When no intent is documented, the code defaults to accidental.

The 7th character D fits once active treatment is over and the patient is receiving routine care while they recover.

Place, activity and status codes (Y92, Y93 and Y99) belong to the initial encounter, so they stay off a T52.0X3D claim.

Claims software like Pabau pre-fills the claim from the patient record and checks required fields, but your coder still picks the 7th character.

ICD-10 code T52.0X3D tags the follow-up visit, not the emergency

ICD-10 code T52.0X3D is the billable diagnosis code for a follow-up visit after an assault involving a petroleum product. Think gasoline, kerosene or naphtha used against a patient by another person.

Timing is the detail that matters most. The D means active treatment has ended and the patient is back for routine care while they recover. Code that visit with an A, or skip the assault documentation, and the claim is likely to come back.

Below, you’ll find the quick-reference data, the intent and encounter rules, the external cause codes that drop off at follow-up, and a pre-submission checklist.

The CDC/NCHS ICD-10-CM web tool is the official US source for this code’s annual validity and the inclusion terms under T52.0. Check it against the latest fiscal year release before you bill.

Six petroleum products fall under T52.0, and methanol isn’t one of them

The CDC tabular list, which also sits on the CMS ICD-10 page, names six inclusion terms under T52.0. Match the chart against these terms rather than trade names.

• Gasoline [petrol]
• Kerosene [paraffin oil]
• Paraffin wax
• Ether petroleum
• Naphtha petroleum
• Spirit petroleum

The clinician should name the substance, or at least confirm it’s a petroleum product. A coder can’t infer it from the setting alone.

Several look-alikes code elsewhere. Methanol (methyl alcohol) goes to T51.1. Ethylene glycol goes to T51.8X, Toxic effect of other alcohols. And halogen derivatives of aliphatic and aromatic hydrocarbons sit in T53.-, under an Excludes1 note at T52.

The D in T52.0X3D means active treatment is over

The 7th character records where the patient is in their care, not how sick they are. The FY2026 guidelines define D as routine care during the healing or recovery phase, after active treatment ends. All three options apply to T52.0X3.

Here’s the classic error. A coder keeps using A for the whole course of care because it feels natural. But A only fits while active treatment continues. Once the visit is about monitoring, lab follow-up or routine checks, switch to D.

Skip the aftercare Z codes here, too. The guidelines use the D character, not a Z code, for follow-up care of injuries and poisonings.

Assault intent only counts when the chart spells it out

The 6th character 3 means another person caused the exposure, and the record has to say so. Coders can’t assign assault from a hunch or the circumstances. The tabular note for T51-T65 sets the fallback: when no intent is documented, code accidental.

Undetermined intent has a narrow use. It fits only when the record specifically states that the intent can’t be determined.

Compare two notes. “Patient states substance was added to food by partner” documents assault, so the 3 applies. “Toxic ingestion, mechanism unclear” states no intent, so the code falls back to 1. Only a note saying intent can’t be established supports a 4.

T52.0X3D sits one character away from five easy mix-ups

Codes in the T52.0X3 family share the assault intent and differ only in the 7th character. Most selection errors, though, happen on the intent axis. Here’s how T52.0X3D compares with its closest neighbors.

If the assault also led to a mental health diagnosis, code that condition separately. It doesn’t change the T52 code.

Still recovering or living with the aftermath? That’s D versus S

Ask one question: is the toxic effect itself still the reason for the visit? If yes, use D. If it has resolved and a complication remains, use S.

• Subsequent encounter (D): Active treatment is over, but the toxic effect is still being monitored. The patient returns for lab checks, symptom review or aftercare.
• Sequela (S): The toxic effect has resolved, and a late effect remains, such as chronic chemical hepatitis months after ingestion. Code the complication first, then add T52.0X3S.

In practice, “return visit for ongoing monitoring of kerosene ingestion effects” supports D. “Liver damage from prior petroleum ingestion, toxic condition resolved” supports the liver code, followed by T52.0X3S. Choosing S too early tells the payer the condition has resolved when it hasn’t.

Most external cause codes drop off at the follow-up visit

On a T52.0X3D claim, you usually report no Y92, Y93 or Y99 code at all. Here’s why, rule by rule, from the FY2026 ICD-10-CM Official Guidelines.

• Intent is already built in. No Chapter 20 code is needed when a code from another chapter already carries the cause and intent. The 3 in T52.0X3D does that job.
• Place of occurrence (Y92.x) is generally assigned only once, at the initial encounter for treatment. It doesn’t carry forward to the D visit.
• Activity (Y93.x) is also used only once, at the initial encounter. The guidelines don’t apply activity codes to poisonings, adverse effects or sequelae. For reference, Y93.89 is “Activity, other specified” and Y93.9 is “Activity, unspecified.”
• External cause status (Y99.x) follows the same once-only rule. It also doesn’t apply to poisonings or late effects.

There’s also no national mandate to report external cause codes. Some states and payers require them, so check those rules for the initial claim. On the follow-up claim, add codes for any ongoing manifestation instead, such as a respiratory condition from J60-J70.

Four chart details make a T52.0X3D claim defensible

An auditor will look for four things in the note. If any one of them is missing, the claim gets harder to defend.

1. Assault confirmed in the record. The note states that another person caused the exposure. A patient’s account recorded by the clinician (“patient reports substance was placed in her drink by a former partner”) is enough. The coder’s inference isn’t.
2. Petroleum product identified. Name the substance where possible, using terms like gasoline, kerosene or naphtha. If it’s unknown, the clinician can document “petroleum-based substance.” Alcohols such as methanol code to T51 instead.
3. Encounter documented as follow-up. The note makes clear that active treatment has ended. Phrases like “return visit for monitoring” or “routine post-exposure check” support the D.
4. Earlier active treatment referenced. Point back to the initial treatment, whether it happened at your practice or elsewhere. A date and facility name in the note answers the payer’s first question.

Five coding errors that sink a T52.0X3D claim, and how to prevent each

These errors are predictable, so it’s cheaper to catch them before submission than to rework a denial. When one does slip through, the remittance tells you why. Our guide to the denial codes billers see decodes each reason.

Fix these five and you’re far closer to a clean claim that the payer can process without coming back to you.

Run this five-point check before a T52.0X3D claim goes out

Use it at charge entry, after coding and before submission. Each line should get a clear yes.

• The note says another person caused the exposure.
• The substance is a named or confirmed petroleum product.
• Active treatment has ended, and the note calls this visit a follow-up.
• No Y92, Y93 or Y99 codes have carried over from the initial claim.
• Codes for any ongoing manifestation are listed after T52.0X3D.

Twelve codes share the T52.0X root, and T52.0X3D is one of them

Checking the hierarchy first confirms you’re in the right chapter and category. Then you can pick the 6th and 7th characters with confidence.

T52.0X3 isn’t billable on its own, so every claim needs the full 7-character code. The T52.0X subcategory holds 12 billable codes in total: four intents, each with an A, D or S. The grid below maps all 12.

How claims software keeps T52.0X3D follow-up claims moving

Many billing teams still re-key diagnosis codes from the note into the claim form by hand. Then they wait to hear whether the payer accepted it. Each re-keyed field is another chance for a wrong 7th character to slip through.

Practice management software like Pabau shortens that loop. Its claims software for practices pre-fills the claim from the patient record and includes an ICD-10-CM code library for lookups. It also checks that required claim fields are complete before you send.

In the US, claims go out through the Claim.MD clearinghouse, with eligibility checks, remittance posting and status tracking built in. Pabau doesn’t choose the intent or encounter character for you. Your coder still makes that call, backed by what the note says.

Send cleaner T52.0X3D follow-up claims

Pabau pre-fills claims from the patient record, checks required fields before you send, and submits through Claim.MD in the US. Your team spends less time re-keying codes and chasing rejected claims.

Book a demo

Conclusion

T52.0X3D hangs on two sentences in the note. One says another person caused the exposure. The other says active treatment is over.

Get your clinicians writing both, and the coding follows without guesswork. Leave either one out, and the defensible code becomes accidental or initial instead. Querying the chart takes minutes, while defending an unsupported code on audit can take weeks.

If your team still re-keys these claims by hand, that step is the easiest one to take off their plate. Book a demo to see how Pabau pre-fills and submits follow-up claims like this one.

Continue your research

Coding a different toxic exposure? ICD-10 code T57.8X1A covers the accidental toxic effect of other inorganic substances, with the same intent and encounter logic.

Working with undetermined intent? ICD-10 code T56.7X4A shows how the undetermined intent character works on a beryllium toxic effect code.

Need help with denial patterns on toxic exposure codes? Denial management in healthcare covers the workflow steps practices use to reduce first-pass denial rates across complex diagnosis codes.

Want to understand claim submission for ICD-10 codes? What is revenue cycle management explains how coding accuracy connects to the full billing and collection cycle.

Looking for clearinghouse options for US claims? Medical claims clearinghouse outlines how clearinghouses validate and route claims before they reach payers, and what to look for in a clearinghouse partner.

Frequently asked questions